ICU · Obstetric critical care
Pre-eclampsia, Eclampsia & HELLP Syndrome
Also known as Pre-eclampsia · Eclampsia · HELLP syndrome · Magnesium sulfate · Calcium gluconate antidote · Postpartum pre-eclampsia
The hypertensive spectrum of pregnancy spans pre-eclampsia (new hypertension over 140 over 90 plus proteinuria or end-organ dysfunction after 20 weeks), eclampsia (plus seizures), and HELLP (haemolysis, elevated liver enzymes, low platelets). The mechanism is abnormal placentation releasing anti-angiogenic sFlt-1, driving generalised endothelial dysfunction. Management is magnesium sulfate for seizure prophylaxis and treatment (calcium gluconate is the antidote), controlled blood-pressure reduction with labetalol, hydralazine, or nifedipine, and delivery as the definitive cure.
Checked against its sources on 3 Sept 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Meet the patient
A 29-year-old primigravida at 38 weeks gestation is brought to the emergency department after a two-minute generalised tonic-clonic seizure at home. She is post-ictal, drowsy, and confused. Her blood pressure is 172 over 114, she has gross peripheral and facial oedema, brisk reflexes with six beats of clonus, and proteinuria of 4.2 g per day. Her platelets are 88, AST 165, and LDH 720 with schistocytes on the smear.[2][7]
Three questions. Has she seized (magnesium now)? Is her blood pressure over 160 systolic or 110 diastolic (urgent antihypertensive therapy — as soon as possible within 30 to 60 minutes — to reduce the risk of maternal stroke)? Does she need delivery (the definitive treatment)? This woman has eclampsia with HELLP — all three answers are yes.[2][8][10]
References21ShowHide
- [1]Hauspurg A, Jeyabalan A Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy Am J Obstet Gynecol, 2022.PMID 35177218
- [2]Fishel Bartal M, Sibai BM Eclampsia in the 21st century Am J Obstet Gynecol, 2022.PMID 32980358
- [3]Adorno M, Maher-Griffiths C, Grush Abadie HR HELLP Syndrome Crit Care Nurs Clin North Am, 2022.PMID 36049847
- [4]Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial Lancet, 2002.PMID 12057549
- [5]The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial Lancet, 1995.PMID 7769899
- [6]Lu JF, Nightingale CH Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles Clin Pharmacokinet, 2000.PMID 10803454
- [7]Sibai BM Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count Obstet Gynecol, 2004.PMID 15121574
- [8]Tranquilli AL, Brown MA, Zeeman GG, et al. The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Pregnancy Hypertens, 2013.PMID 26105740
- [9]Zeisler H, Llurba E, Chantraine F, et al. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia N Engl J Med, 2016.PMID 26735990
- [10]American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 767 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period Obstet Gynecol, 2019.PMID 30681541
- [11]Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy N Engl J Med, 2015.PMID 25629739
- [12]von Dadelszen P, Payne B, Li J, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model Lancet, 2011.PMID 21185591
- [13]Rolnik DL, Wright D, Poon LC, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia N Engl J Med, 2017.PMID 28657417
- [14]Darby M, Martin JN Jr, Mitchell SQ, et al. Using case reports to determine when liver bleeding occurs during disease progression in HELLP syndrome Int J Gynaecol Obstet, 2013.PMID 23871223
- [15]Boushra M, Natesan SM, Koyfman A, Long B High risk and low prevalence diseases: Eclampsia Am J Emerg Med, 2022.PMID 35716535
- [16]Euser AG, Cipolla MJ Magnesium sulfate for the treatment of eclampsia: a brief review Stroke, 2009.PMID 19211496
- [17]Lippert TH [Use of magnesium sulfate as an anticonvulsant in severe pregnancy toxemia and eclampsia]. Geburtshilfe Frauenheilkd, 1983.PMID 6557975
- [18]Omu AE, Al-Harmi J, Vedi HL, et al. Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait Med Princ Pract, 2008.PMID 18408392
- [19]Haram K, Svendsen E, Abildgaard U The HELLP syndrome: clinical issues and management. A Review BMC Pregnancy Childbirth, 2009.PMID 19245695
- [20]Vigil-De Gracia P, Lasso M, Ruiz E, et al. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial Eur J Obstet Gynecol Reprod Biol, 2006.PMID 16621226
- [21]Adebayo JA, Nwafor JI, Lawani LO, et al. Efficacy of nifedipine versus hydralazine in the management of severe hypertension in pregnancy: A randomised controlled trial Niger Postgrad Med J, 2020.PMID 33154284